Clinical Trial Update: Polaprezinc (Zinc L-carnosine) in Infants With Gastroesophageal Reflux [NA]

View source ↗

Summary

A clinical trial is planned to evaluate Polaprezinc (Zinc L-carnosine) for gastroesophageal reflux in infants; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux

Drugs mentioned

• Polaprezinc (Zinc L-carnosine)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Gastroesophageal Reflux (GER), Infants | NA | Status: NOT_YET_RECRUITING